New York City says it has met a target in the fight against HIV/AIDS two years ahead of schedule
In 2018, 93% of New York City residents knew their HIV status, 90% were on treatment and 92% were on treatment had suppressed viral loads, ahead of the city's 2020 target of 90-90-90.
[New Times] The United Nations Programme for HIV/AIDS (UNAIDS) target of ending the AIDS epidemic by 2030 will remain a mirage if children and young people are not given access to Anti-retro viral treatment, medics have said.
[New Times] We are just a few days away to the year 2020, where the world will have to have achieved the 90-90-90 target that stipulates; 90 per cent of all people living with HIV will know their HIV status, 90 per cent of all people with diagnosed HIV infection will receive sustained antiretroviral therapy and 90 per cent of all people receiving antiretroviral therapy will have viral suppression.
[New Times] The 20th International Conference on AIDS and STIs in Africa (ICASA) 2019 will conclude its seven-day activities on Saturday, December 7.
[UNFPA] KIGALI, Rwanda, International Conference on AIDS and STIs in Africa (ICASA)--As the pillars of our communities, girls have the agency to bring about change for themselves and those around them, said Jeannette Kagame, Rwanda's First Lady.
GlaxoSmithKline Plc said on Thursday its HIV unit has submitted a new drug application to the U.S. Food and Drug Administration seeking approval for fostemsavir, an experimental treatment for HIV in adults.Reuters Health Information
In conclusion, upgrading the Sinan-TB database through integration with other information systems improved the data's quality for decision-making on TB control. PMID: 31800783 [PubMed - in process]
PMID: 31800273 [PubMed - in process]
Decrease due to drops in generic drug prices and slow growth in the cost of brand - name medications
AbstractWe explored the association between HIV-related stigma and experiences of intimate partner violence (IPV) and depression with viral load suppression, and medication and visit adherence in postpartum women receiving lifelong antiretroviral therapy (ART) (N = 200). We administered a cross-sectional survey to 200 women with HIV at 12 months postpartum who were enrolled in the MOTIVATE trial. The MOTIVATE study is a cluster-randomized trial evaluating the impact of community mentor mothers and text messaging on PMTCT outcomes in southwestern Kenya. Simple and multivariable logistic regression analys...
AbstractStudies have documented how levels and change in depression correspond to ART non-adherence. However, few studies have examined how levels of and change in adherence may relate to levels of and change in depression, although one might expect mental health to be related to physical health and how successful one is in managing disease. To assess the bidirectional nature of the association between these two constructs, we examined data from a prospective trial of an ART adherence intervention in Uganda that followed 143 participants over 20 months. Adherence was measured using electronic monitoring caps; non-adh...